Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Market Closed - BME Other stock markets 11:43:12 2026-07-24 am EDT			5-day change	1st Jan Change
58.80 ^EUR	+1.20%		+9.50%	-7.40%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.38B		BBB
ELI LILLY AND COMPANY	1,057B		A
JOHNSON & JOHNSON	624B		BBB
ABBVIE INC.	454B		AA	-
ROCHE HOLDING AG	341B		AA
NOVARTIS AG	297B		AAA
ASTRAZENECA PLC	262B		A
NOVO NORDISK A/S	215B		A
AMGEN INC.	201B		A
GILEAD SCIENCES, INC.	162B		AA
PFIZER INC.	143B		A
BRISTOL-MYERS SQUIBB COMPANY	126B		A
VERTEX PHARMACEUTICALS INCORPORATED	120B		AA
SANOFI	104B		AA
GSK PLC	101B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	72.43B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	53.64B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	53.47B		AA
BAYER AG	51.61B		AA
Average	225.29B		AA
Weighted average by Cap.			AA